Cellectis S.A. (EPA:ALCLS)

Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of EUR 225.40 million. The enterprise value is 123.46 million.

Market Cap	225.40M
Enterprise Value	123.46M

Important Dates

The last earnings date was Thursday, March 19, 2026.

Earnings Date	Mar 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Cellectis has 72.59 million shares outstanding. The number of shares has increased by 10.73% in one year.

Current Share Class	72.59M
Shares Outstanding	72.59M
Shares Change (YoY)	+10.73%
Shares Change (QoQ)	-1.36%
Owned by Insiders (%)	2.19%
Owned by Institutions (%)	16.38%
Float	46.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.32
PB Ratio	3.49
P/TBV Ratio	3.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.14
EV / Sales	1.82
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.47

Financial Position

The company has a current ratio of 1.62, with a Debt / Equity ratio of 1.14.

Current Ratio	1.62
Quick Ratio	1.59
Debt / Equity	1.14
Debt / EBITDA	n/a
Debt / FCF	-2.08
Interest Coverage	-4.08

Financial Efficiency

Return on equity (ROE) is -65.33% and return on invested capital (ROIC) is -10.83%.

Return on Equity (ROE)	-65.33%
Return on Assets (ROA)	-5.84%
Return on Invested Capital (ROIC)	-10.83%
Return on Capital Employed (ROCE)	-18.48%
Weighted Average Cost of Capital (WACC)	16.25%
Revenue Per Employee	298,632
Profits Per Employee	-253,608
Employee Count	229
Asset Turnover	0.22
Inventory Turnover	n/a

Taxes

Income Tax	-360,269
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +138.11% in the last 52 weeks. The beta is 2.71, so Cellectis's price volatility has been higher than the market average.

Beta (5Y)	2.71
52-Week Price Change	+138.11%
50-Day Moving Average	3.23
200-Day Moving Average	3.03
Relative Strength Index (RSI)	50.62
Average Volume (20 Days)	192,278

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cellectis had revenue of EUR 67.79 million and -57.57 million in losses. Loss per share was -0.57.

Revenue	67.79M
Gross Profit	67.79M
Operating Income	-28.17M
Pretax Income	-57.93M
Net Income	-57.57M
EBITDA	-18.52M
EBIT	-28.17M
Loss Per Share	-0.57

Balance Sheet

The company has 175.77 million in cash and 73.83 million in debt, with a net cash position of 101.94 million or 1.40 per share.

Cash & Cash Equivalents	175.77M
Total Debt	73.83M
Net Cash	101.94M
Net Cash Per Share	1.40
Equity (Book Value)	64.64M
Book Value Per Share	0.89
Working Capital	77.07M

Cash Flow

In the last 12 months, operating cash flow was -33.56 million and capital expenditures -2.01 million, giving a free cash flow of -35.57 million.

Operating Cash Flow	-33.56M
Capital Expenditures	-2.01M
Depreciation & Amortization	9.81M
Net Borrowing	-14.03M
Free Cash Flow	-35.57M
FCF Per Share	-0.49

Margins

Gross margin is 100.00%, with operating and profit margins of -41.56% and -84.92%.

Gross Margin	100.00%
Operating Margin	-41.56%
Pretax Margin	-85.45%
Profit Margin	-84.92%
EBITDA Margin	-27.33%
EBIT Margin	-41.56%
FCF Margin	n/a

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.73%
Shareholder Yield	-10.73%
Earnings Yield	-25.54%
FCF Yield	-15.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellectis has an Altman Z-Score of -0.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.76
Piotroski F-Score	2